Quantitative MRI of cartilage and bone: degenerative changes in osteoarthritis

Authors

  • Felix Eckstein,

    Corresponding author
    1. Institute of Anatomy and Musculoskeletal Research, Paracelsus Private Medical University (PMU), A-5020 Salzburg, Austria
    2. Chondrometrics GmbH, Ainring 83404, Germany
    • Institute of Anatomy and Musculoskeletal Research, Paracelsus Private Medical University (PMU), Strubergasse 21, A-5020 Salzburg, Austria.
    Search for more papers by this author
  • Deborah Burstein,

    1. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
    Search for more papers by this author
  • Thomas M. Link

    1. Department of Radiology, University of California, San Francisco, CA 94143, USA
    Search for more papers by this author

Abstract

Magnetic resonance imaging (MRI) and quantitative image analysis technology has recently started to generate a great wealth of quantitative information on articular cartilage and bone physiology, pathophysiology and degenerative changes in osteoarthritis. This paper reviews semiquantitative scoring of changes of articular tissues (e.g. WORMS = whole-organ MRI scoring or KOSS = knee osteoarthritis scoring system), quantification of cartilage morphology (e.g. volume and thickness), quantitative measurements of cartilage composition (e.g. T2, T1rho, T1Gd = dGEMRIC index) and quantitative measurement of bone structure (e.g. app. BV/TV, app. TbTh, app. Tb.N, app. Tb.Sp) in osteoarthritis. For each of these fields we describe the hardware and MRI sequences available, the image analysis systems and techniques used to derive semiquantitative and quantitative parameters, the technical accuracy and precision of the measurements reported to date and current results from cross-sectional and longitudinal studies in osteoarthritis. Moreover, the paper summarizes studies that have compared MRI-based measurements with radiography and discusses future perspectives of quantitative MRI in osteoarthritis. In summary, the above methodologies show great promise for elucidating the pathophysiology of various tissues and identifying risk factors of osteoarthritis, for developing structure modifying drugs (DMOADs) and for combating osteoarthritis with new and better therapy. Copyright © 2006 John Wiley & Sons, Ltd.

Ancillary